This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Verify budget accuracy with practical checks that align your projected spending to actuals. This quick intro helps you spot misalignments and tighten your budget.
11,585 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
NVIDIA CEO Jensen Huang predicts AI agents will infiltrate every function in every company, signaling a new phase for...
In this analysis, we unpack what Andy Jassy's recent remarks mean for Amazon stock and AWS growth. Learn actionable s...
Micron Technology posted strong results, yet the stock slipped. This guide weighs whether micron's dip: great chance ...
Prentice Capital has exited its Compass position, reporting a zero stake after the latest quarter. This move highligh...
The connection between AI investment and inflation could reshape markets. This practical guide translates Powell's re...
MP Materials is at the center of America’s push to secure essential minerals. This guide breaks down whether now is t...
When a tech titan speaks, markets listen. This article breaks down NVIDIA's latest signals from the GTC AI conference...
Arm is venturing into silicon design after decades as a licensing powerhouse. This bold shift could impact AI data ce...
The U.S. Postal Service plans an 8% surcharge on package deliveries beginning April 2026, marking the first such fee ...
Bluesky is carving a new path in social media by using an open, federated protocol. This article explains what Bluesk...
Oil tensions linked to Iran have put pressure on stocks, lifting energy prices and weighing on the S&P 500 and Nasdaq...